Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

DaVita (DVA) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical Care FacilitiesDVA

Closing price · Nov 19, 2026 $155.94 -3.6% on the day · +35.4% over 12 months 52-week range $103.87 – $240.96
Get DVA alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling6last 12 months
Reported sales$523M3 of 14 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Jan 29, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Berkshire Hathaway Inc, 10% Owner sold 382,563 shares at $180.43 ($69.0M).

Trade date
Oct 27, 2026
Disclosed to the SEC
Oct 29, 2026
Type
Sale (code S)

Read the original SEC filing ↗All DVA insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

DVA insider transactions (Form 4)

Open-market purchases and sales. 82 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Oct 29SEC Berkshire Hathaway Inc10% Owner Sell 382,56328,314,666 held (−1%) $180.43 $69.0M -13.6% —
Aug 4SEC Berkshire Hathaway Inc10% Owner Sell 182,98028,697,229 held (−1%) $199.55 $36.5M -21.9% —
Jun 17SEC Javier RodriguezCEO Sell 39,407840,408 held (−4%) $209.28 $8.2M -25.5% —
Jun 17SEC Javier RodriguezCEO Sell 30,000879,815 held (−3%) $209.50 $6.3M -25.6% —
Jun 17SEC Kathleen Alyce WatersGeneral Counsel Sell Plan 8,950115,649 held (−7%) $207.84 $1.9M -25.0% —
Jun 17SEC Kathleen Alyce WatersGeneral Counsel Sell Plan 6,455109,194 held (−6%) $209.17 $1.4M -25.4% —
May 18SEC James O. HeartyChief Compliance Officer Sell 15,00022,389 held (−40%) $193.98 $2.9M -19.6% —
May 13SEC David Paul MaughanCOO Sell 13,45694,105 held (−13%) $199.25 $2.7M -21.7% —
May 13SEC David Paul MaughanCOO Sell 7,073107,561 held (−6%) $199.15 $1.4M -21.7% —
May 11SEC Joel AckermanCFO Sell 51,471132,434 held (−28%) $192.10 $9.9M -18.8% —
May 8SEC James O. HeartyChief Compliance Officer Sell Plan 2,18435,953 held (−6%) $174.87 $382K -10.8% —
May 5SEC Berkshire Hathaway Inc10% Owner Sell 1,220,37628,880,209 held (−4%) $149.84 $183M +4.1% —
Feb 2SEC Berkshire Hathaway Inc10% Owner Sell 1,658,48030,100,585 held (−5%) $120.56 $200M +29.4% —
Oct 29SEC Berkshire Hathaway Inc10% Owner Sell 401,51431,759,065 held (−1%) $135.36 $54.3M +15.2% —
Historical context

Similar past setups: not applicable. DVA has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with DVA in the Research Lab

DVA has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

DVA closeInsider buyInsider sale
100150200250DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-02EEarnings release filed 2026-05-05EEarnings release filed 2026-08-04EEarnings release filed 2026-10-29Sold $381,916 on 2026-05-06 · James O. HeartySold $1,408,581 on 2026-05-11 · David Paul MaughanSold $2,681,162 on 2026-05-12 · David Paul MaughanSold $2,909,745 on 2026-05-15 · James O. HeartySold $8,247,018 on 2026-06-16 · Javier RodriguezSold $9,495,467 on 2026-06-15 · Javier Rodriguez, Kathleen Alyce WatersSold $9,887,528 on 2026-05-07 · Joel AckermanSold $36,513,293 on 2026-07-31 · Berkshire Hathaway IncSold $69,026,033 on 2026-10-27 · Berkshire Hathaway IncSold $182,864,679 on 2026-05-01 · Berkshire Hathaway IncSold $199,939,881 on 2026-01-29 · Berkshire Hathaway Inc
Bought, 12 months$0
Sold, 12 months$523M
Insiders buying0
Insiders selling6

DaVita insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 6 sold $523M of DVA stock on the open market; P/E 15.1 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

DVA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $54.3M sold (1 trades)Q4 2025Q1 2026: $200M sold (1 trades)Q1 2026Q2 2026: $218M sold (10 trades)Q2 2026Q3 2026: $36.5M sold (1 trades)Q3 2026Q4 2026: $69.0M sold (1 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$69.0M1
Q3 2026—0$36.5M1
Q2 2026—0$218M10
Q1 2026—0$200M1
Q4 2025—0$54.3M1

Valuation, profit and volume

P/E (trailing)15.1Sector median 25.0
Market value$11.40BMedical Care Facilities
Profit margin6.0%Revenue growth +5.2%
Volume vs. 50-day0.9×Last 5 sessions

Source: Yahoo Finance, as of Oct 5, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 DaVita insiders reported open-market purchases totaling $0, while 6 insiders reported sales totaling $523M. Among insiders with enough purchase history to measure, Wendy Lee Schoppert (Director) has the highest Insider Score at 96. 3 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

DVA earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 29, 2026 +1.0% Sold $69.0M +1.9%S&P -2.1% pending
Aug 4, 2026 -1.4% Sold $36.5M -19.3%S&P +1.6% -2.5%
May 5, 2026 +4.2% Sold $183M +25.8%S&P +2.2% -0.9%
Feb 2, 2026 +3.3% Sold $200M +23.2%S&P -0.4% +11.3%
Oct 29, 2025 +4.6% Sold $54.3M -8.4%S&P -1.1% +0.8%
Aug 5, 2025 -1.2% None -8.4%S&P +0.3% +7.9%
May 12, 2025 +3.0% None +0.2%S&P +4.0% -4.6%
Feb 13, 2025 -0.7% None -8.5%S&P +1.1% -8.9%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

DVA short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 78% of volume sold short2026-08-27: 62% of volume sold short2026-08-28: 79% of volume sold short2026-08-31: 73% of volume sold short2026-09-01: 64% of volume sold short2026-09-02: 71% of volume sold short2026-09-03: 79% of volume sold short2026-09-04: 79% of volume sold short2026-09-08: 79% of volume sold short2026-09-09: 80% of volume sold short2026-09-10: 88% of volume sold short2026-09-11: 76% of volume sold short2026-09-14: 73% of volume sold short2026-09-15: 76% of volume sold short2026-09-16: 75% of volume sold short2026-09-17: 86% of volume sold short2026-09-18: 85% of volume sold short2026-09-21: 81% of volume sold short2026-09-22: 84% of volume sold short2026-09-23: 72% of volume sold short2026-09-24: 80% of volume sold short2026-09-25: 76% of volume sold short2026-09-28: 78% of volume sold short2026-09-29: 69% of volume sold short2026-09-30: 68% of volume sold short2026-10-01: 77% of volume sold short2026-10-02: 70% of volume sold short2026-10-05: 60% of volume sold short2026-10-06: 58% of volume sold short2026-10-07: 72% of volume sold short2026-10-08: 69% of volume sold short2026-10-09: 67% of volume sold short2026-10-12: 72% of volume sold short2026-10-13: 60% of volume sold short2026-10-14: 76% of volume sold short2026-10-15: 62% of volume sold short2026-10-16: 80% of volume sold short2026-10-19: 83% of volume sold short2026-10-20: 72% of volume sold short2026-10-21: 61% of volume sold short2026-10-22: 73% of volume sold short2026-10-23: 81% of volume sold short2026-10-26: 81% of volume sold short2026-10-27: 83% of volume sold short2026-10-28: 79% of volume sold short2026-10-29: 87% of volume sold short2026-10-30: 78% of volume sold short2026-11-02: 79% of volume sold short2026-11-03: 74% of volume sold short2026-11-04: 58% of volume sold short2026-11-05: 61% of volume sold short2026-11-06: 59% of volume sold short2026-11-09: 83% of volume sold short2026-11-10: 66% of volume sold short2026-11-11: 79% of volume sold short2026-11-12: 89% of volume sold short2026-11-13: 86% of volume sold short2026-11-16: 85% of volume sold short2026-11-17: 80% of volume sold short2026-11-18: 78% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 78%20-day average: 77%Prior 2 months: 74%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded DVA

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +1.0%

Insiders at DaVita

InsiderBoughtSoldLast filingPast buys beat S&PScore
Berkshire Hathaway Inc10% Owner — $543M Oct 29, 2026 0 of 1 —
Javier RodriguezCEO — $14.5M Nov 17, 2026 — —
Joel AckermanCFO — $9.9M May 11, 2026 — —
David Paul MaughanCOO — $4.1M Sep 24, 2026 — —
James O. HeartyChief Compliance Officer — $3.3M May 18, 2026 — —
Kathleen Alyce WatersGeneral Counsel — $3.2M Jun 17, 2026 — —
Christopher Michael BerryChief Accounting Officer — — Nov 17, 2026 0 of 1 —
Phyllis R. YaleDirector — — Nov 17, 2026 — —
Wendy Lee SchoppertDirector — — Nov 17, 2026 — 96
Dennis W. PullinDirector — — Nov 17, 2026 — —
Adam H. SchechterDirector — — Nov 17, 2026 — —
Jason M. HollarDirector — — Nov 17, 2026 — —
Gregory J. MooreDirector — — Nov 17, 2026 — —
Barbara J. DesoerDirector — — Nov 17, 2026 — —
Pamela M. ArwayDirector — — Nov 17, 2026 — —

Board links: companies that share insiders with DVA

Directors and executives who filed Form 4s for DVA and another company in the last 12 months.

See the map →
  • CAHCardinal Health Jason M. Hollar Director here · CEO at CAH · latest filing Nov 17, 2026
  • FOSLFossil Group Wendy Lee Schoppert Director here · Director at FOSL · latest filing Nov 17, 2026
  • FTVFortive Gregory J. Moore Director here · Director at FTV · latest filing Nov 17, 2026
  • GILDGilead Sciences Javier Rodriguez CEO here · Director at GILD · latest filing Nov 17, 2026
  • IRMIron Mountain Pamela M. Arway Director here · Director at IRM · latest filing Nov 17, 2026
  • LHLabcorp Adam H. Schechter Director here · CEO, President at LH · latest filing Nov 17, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

DVA stock: common questions

Are DaVita insiders buying DVA stock?

No. No DaVita insider reported an open-market purchase of DVA in the past 12 months.

Are DaVita insiders selling DVA stock?

6 insiders reported sales worth $523M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is DVA's P/E ratio?

DVA trades at about 15.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is DVA's 52-week range?

Over the past year DVA has traded between $103.87 and $240.96. It last closed at $155.94 on Nov 19, 2026.